With reference to the subject cited, this is to inform the Exchange that the meeting of the Board of Directors of Prism Medico and Pharmacy Limited held on Tuesday, May 05, 2026 at the ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
The Board of Directors of Prism Medico and Pharmacy Limited approved the allotment of 75 lakh equity shares and 50 lakh convertible warrants, both at ₹10 per share/warrant on a preferential basis. The total capital raised is ₹125 lakh (₹75 lakh in equity + ₹50 lakh in warrants). The allotment was conducted pursuant to a special resolution passed at an Extra-Ordinary General Meeting held on March 20, 2026, and in-principle approval from BSE received on March 25, 2026. The shares and warrants were issued at face value, indicating this is likely a promoter or related-party funding round rather than a market-priced placement. The meeting commenced at 11:00 AM and concluded at 4:00 PM.
The preferential issuance at face value (no premium) dilutes existing shareholders. Convertible warrants, if exercised, will cause further dilution. The small capital raise may be targeted at supporting operations or reducing debt, but the low issue price raises concerns about fairness to minority shareholders.